Reflexión - Open Access .click

Results 281 to 290 of about 1,073,593 (298)

Blood pressure effects of SGLT2 inhibitors and GLP‐1 receptor agonists: Mechanisms, trial evidence and Real‐world data

British Journal of Clinical Pharmacology, EarlyView.
SGLT2 inhibitors and GLP‐1 receptor agonists modestly lower blood pressure across diverse patient populations, including those without diabetes. These effects appear largely independent of glycaemic control and offer additive value in high‐risk patients with overlapping comorbidities.
Andrej Belančić +7 more
wiley +1 more source

XXXIV Congreso de Comunicación y Salud de la semFYC - Un espacio esencial para la Atención Primaria. [PDF]

Aten Primaria
Barragán MR, Fontcuberta JMB.
europepmc +1 more source

[Anti-obesity drugs and potential changes in the epidemiology of this condition and in cardiovascular risk factors]. [PDF]

Aten Primaria
Cuatrecasas G.
europepmc +1 more source

Impact of educational interventions on the cultural competencies of nurses and students: a systematic review and meta-analysis. [PDF]